Konstantinos Farsalinos

InstitutionUniversity of Patras
AddressPatras
Greece
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 15 Covid-19 publications, with a maximum of 3 publications in June 2020 and January 2021
    All Publications
    Bar chart showing 34 publications over 9 distinct years, with a maximum of 10 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Farsalinos K, Niaura R. Speculation vs. evidence in the association between e-cigarette use and COVID-19: A response to Soule et al. Prev Med Rep. 2021 Sep; 23:101295. PMID: 34395182.
      Citations: 1     
    2. Tanmay S, Labrou D, Farsalinos K, Poulas K. Is SARS-CoV-2 Spike glycoprotein impairing macrophage function via a7-nicotinic acetylcholine receptors? Food Chem Toxicol. 2021 Jun; 152:112184. PMID: 33838172.
      Citations: 1     Fields:    Translation:HumansCells
    3. Lagoumintzis G, Chasapis CT, Alexandris N, Kouretas D, Tzartos S, Eliopoulos E, Farsalinos K, Poulas K. Nicotinic cholinergic system and COVID-19: In silico identification of interactions between a7 nicotinic acetylcholine receptor and the cryptic epitopes of SARS-Co-V and SARS-CoV-2 Spike glycoproteins. Food Chem Toxicol. 2021 Mar; 149:112009. PMID: 33503469.
      Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
    4. Farsalinos K, Bagos PG, Giannouchos T, Niaura R, Barbouni A, Poulas K. Smoking prevalence among hospitalized COVID-19 patients and its association with disease severity and mortality: an expanded re-analysis of a recent publication. Harm Reduct J. 2021 01 16; 18(1):9. PMID: 33453726.
      Citations: 5     Fields:    Translation:Humans
    5. Farsalinos K, Niaura R. E-Cigarette Use and COVID-19: Questioning Data Reliability. J Adolesc Health. 2021 01; 68(1):213. PMID: 33349352.
      Citations: 2     Fields:    Translation:Humans
    6. Alexandris N, Lagoumintzis G, Chasapis CT, Leonidas DD, Papadopoulos GE, Tzartos SJ, Tsatsakis A, Eliopoulos E, Poulas K, Farsalinos K. Nicotinic cholinergic system and COVID-19: In silico evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions. Toxicol Rep. 2021; 8:73-83. PMID: 33425684.
      Citations: 11     
    7. Farsalinos K, Poulas K, Kouretas D, Vantarakis A, Leotsinidis M, Kouvelas D, Docea AO, Kostoff R, Gerotziafas GT, Antoniou MN, Polosa R, Barbouni A, Yiakoumaki V, Giannouchos TV, Bagos PG, Lazopoulos G, Izotov BN, Tutelyan VA, Aschner M, Hartung T, Wallace HM, Carvalho F, Domingo JL, Tsatsakis A. Improved strategies to counter the COVID-19 pandemic: Lockdowns vs. primary and community healthcare. Toxicol Rep. 2021; 8:1-9. PMID: 33294384.
      Citations: 16     
    8. Farsalinos K, Barbouni A, Niaura R. Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? Reply. Intern Emerg Med. 2021 01; 16(1):235-236. PMID: 32955678.
      Citations: 9     Fields:    Translation:Humans
    9. Farsalinos K, Eliopoulos E, Leonidas DD, Papadopoulos GE, Tzartos S, Poulas K. Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications. Int J Mol Sci. 2020 Aug 13; 21(16). PMID: 32823591.
      Citations: 18     Fields:    Translation:HumansCellsPHPublic Health
    10. Farsalinos K, Angelopoulou A, Alexandris N, Poulas K. COVID-19 and the nicotinic cholinergic system. Eur Respir J. 2020 07; 56(1). PMID: 32444400.
      Citations: 20     Fields:    Translation:HumansCellsPHPublic Health
    11. Farsalinos K, Barbouni A, Poulas K, Polosa R, Caponnetto P, Niaura R. Current smoking, former smoking, and adverse outcome among hospitalized COVID-19 patients: a systematic review and meta-analysis. Ther Adv Chronic Dis. 2020; 11:2040622320935765. PMID: 32637059.
      Citations: 54     
    12. Angelopoulou A, Alexandris N, Konstantinou E, Mesiakaris K, Zanidis C, Farsalinos K, Poulas K. Imiquimod - A toll like receptor 7 agonist - Is an ideal option for management of COVID 19. Environ Res. 2020 09; 188:109858. PMID: 32846644.
      Citations: 22     Fields:    Translation:HumansCellsPHPublic Health
    13. Poulas K, Farsalinos K, Zanidis C. Activation of TLR7 and Innate Immunity as an Efficient Method Against COVID-19 Pandemic: Imiquimod as a Potential Therapy. Front Immunol. 2020; 11:1373. PMID: 32612613.
      Citations: 18     Fields:    Translation:HumansCellsPHPublic Health
    14. Farsalinos K, Barbouni A, Niaura R. Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? Intern Emerg Med. 2020 08; 15(5):845-852. PMID: 32385628.
      Citations: 95     Fields:    Translation:HumansCellsPHPublic Health
    15. Farsalinos K, Niaura R, Le Houezec J, Barbouni A, Tsatsakis A, Kouretas D, Vantarakis A, Poulas K. Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system. Toxicol Rep. 2020; 7:658-663. PMID: 32355638.
      Citations: 88     
    Farsalinos's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (82)
    Explore
    _
    Co-Authors (42)
    Explore
    _
    Similar People (60)
    Explore
    _